chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rashes; Blisters on arm; Body mimicked symptoms of med withdrawal; Chronic itching problem; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "Rashes"; BLISTER (non-serious), outcome "unknown", described as "Blisters on arm"; WITHDRAWAL SYNDROME (non-serious), outcome "unknown", described as "Body mimicked symptoms of med withdrawal"; PRURITUS (non-serious), outcome "unknown", described as "Chronic itching problem". Therapeutic measures were taken as a result of rash, blister, withdrawal syndrome, pruritus.  Additional information: Patient stated after taking Covid Vaccine she was having a lot of rashes, blisters on arm, and body mimicked symptoms of med withdrawal and extremely patient went to dermatologist and urgent care for treatment and was given Nedrol and Medrol dose patch & Atarax. Patient stated constant she has chronic itching problem. Patient stated she gets contact dermatologist rashes.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Swelling at knee joint on the leg the vaccine was injected into.  The swelling WAS NOT at the injection site.  ONLY at the joint.
called the clinic the day after the vaccine to report her lips and tongue had felt tingly and that she is OK now. She declined to come in to be seen. Her daughter, also called, later, to report that  lip and tongue swelling. denies ever having any trouble breathing or any other reaction. This was added to her Electronic medical record and documented .
that evening i started to get a cold feeling down my arm and pain at injection site. later that night i had headache, nausea, body ache no fever very weak.. The next day i had body ache and all the same symptoms again. Then on the on the morning of the 29th woke up at 5:00 woke up to my head was killing  me. Felt like my head was going to explode and  i was disoriented.  and i couldn't  speak. couldn't even see to dial 911 or get my husband and after about 20 minutes or so i was able to get to my husband and he took me to the ER. There they gave me meds to get my blood pressure down and ended up admitting me to make sure i was not having a stroke. was in the hospital until that Sunday afternoon.
Patient experienced dizziness/lightheaded, pale, body wide shaking, face tingly, hypertensive, tachycardic from patient reported baseline.
Excessive crying fever, rash all over, Tylenol every 4-6 hours, fluids.
Breakthrough case admission/ patient expired after 2 vaccines Pfizer 1/28/21 lot# EL9265;  Pfizer 2/25/21 lot# EN6202
Complained of burning and tightness to throat that got progressively worse.  Given EPI SubQ and transported via EMS to ED.
This spontaneous report as received from a nurse refers to a 24 year old male patient. Information regarding patient's medical history, concurrent conditions, concomitant medication, drug reaction, allergies and past therapies were not reported. Concomitant therapies included DTAP. On 26-MAR-2018 the 24 year old patient was vaccinated with a PROQUAD (lot # N020615, expiry date 22-JAN-2019) (dosing regimen and frequency unknown) for prophylaxis. It was reported that the PROQUAD was reconstituted with a properly stored sterile diluent (manufacturer unknown) (Lot # M017520, Expiry date 25-SEP-2018). It was reported that the PROQUAD had no temperature excursions prior to being administered. On 26-MAR-2018 the patient was also administered with first dose of M-M-R II (lot number N020615, expiry date unknown) (dosing regimen and frequency unknown) intramuscularly in the left deltoid for prophylaxis. It was also reported as the PROQUAD was administered instead of M-M-R II and VARIVAX. It was reported that the medication error occurred during the preparation for administration and during administration. It was reported that the patient was vaccinated at a private doctor's office/hospital and the vaccine was purchased with private funds. No adverse events were reported and no prescription drug treatment was needed. It was reported that a temperature excursion did not occur as a result of a reading from a Digital Data Logger. No Product quality complaint was reported. Lot number N020615 is an invalid lot number for M-M-R II.
sick for a week years ago; Initial information received on 28-Nov-2020 regarding an unsolicited valid non-serious social media case received from a consumer (patient) via social media.  This case involves a patient of an unknown demography who was sick for a week years ago (illness), while he/she received INFLUENZA VACCINE.  The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick for a week years ago (illness, non-serious event) (Unknown latency) following the administration of INFLUENZA VACCINE.  No laboratories details reported.   It was not reported if the patient received a corrective treatment.  The outcome of event was unknown, at the time of reporting.  There will be no information on the batch number for this case.
I experienced the first day, a lot of dizziness and nausea within after ew hours afterwards. The next day woke up with pain to my fingers and toes. I also had Covid back in July 2020, i think, I had loss of taste and smell.  My psoriasis flared up, got red and inflamed for about one month and also happened few days later after the vaccine. I also got back pain from the Moderna vaccine.  About one week after I called my PCP due to my back pain and she suggested to wait it out and to take an immunosuppressant drug.   I did feel better in March 2021, but continue with back pain and seeing a rheumatologist and also still have my psoriasis flare-ups.
Extreme body aches fever, tingling in fingers and arm. 36 hours post vaccine I had hives in multiple areas of my body. Due to my history of delayed onset reaction with Zithromax that was associated with lip and tongue tingling and a trip to the ER, I was told not to get the second shot
12MAY98 early evening according to mom high pitched cont screaming for over 3hr;T104 fever ax;very little erythema on inj site;13MAY98 930PM ER T99.8, AP 124, R40;MD stated pt still irritable, eating well;
11/14 admitted w/ lethargy. 11/14 cellulitis restricted to legs bilateral. 11/21 devel vesicles/pustules trunk, thighs, legs. Pt subsequently died due to pneumonia and sepsis. No autopsy was performed.
MONOVALENT VACCINE WAS GIVEN INSTEAD OF BIVALENT BOOSTER THAT WAS NEEDED. NURSE DISCOVERED THIS ERROR THE NEXT DAY AFTER VACCINATION
pt recv vax; 1wk later,devel swelling & nodule at inject site, which radiated to finger tips;pain worsened over 3 wk;
Information has been received from a licensed practical nurse concerning a 12 year old female with no medical history or drugs allergies, who in October 2009, was vaccinated with a first dose of GARDASIL. In November 2009, less than four weeks after the GARDASIL, she started to lost all her hair. The patient was treated with CLODERM. The patient sought medical attention through an office visit. At the time of this report the patient was recovering and the hair has started to grow back. Additional information has been requested.
I was having severe leg and chest pain progressively getting worse over two weeks. Went to Urgent Care and they sent me to the Emergency Room. Diagnosed with a blood clot in my left leg. Xarelto (blood thinner) prescribed and still taking Xarelto 1/per day 20mg. Blood clot has not resolved after 11 months.
Welt, redness, swelling, pain at injection site starting morning after injection (normal injection site reaction). Blister showing up by nose 8 days after shot (unsure if shingles). Patient called her doctor and was told to go to the ER where they put her on a 10 day course of antibiotics.
I was not able to work; seizure; nauseas; hurt in my joints; constant headache; arm was hurting to my elbow; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (seizure) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Seizures (Seizure free since Feb-2021.).    On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting to my elbow) and HEADACHE (constant headache). On 22-Jun-2021, the patient experienced NAUSEA (nauseas) and ARTHRALGIA (hurt in my joints). On 25-Jun-2021, the patient experienced SEIZURE (seizure) (seriousness criterion medically significant). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (I was not able to work). At the time of the report, SEIZURE (seizure), PAIN IN EXTREMITY (arm was hurting to my elbow), IMPAIRED WORK ABILITY (I was not able to work), NAUSEA (nauseas), ARTHRALGIA (hurt in my joints) and HEADACHE (constant headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that patient will report to his MD and see if he thinks that patient should get the 2nd dose, but patient is very uncomfortable at this time No concomitant medications were reported.  No treatment information was provided.  Company comment Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Achiness on the arm; a very swollen arm after application, it lasted a day; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced pain in arm and swelling arm. On an unknown date, the outcome of the pain in arm and swelling arm were recovered/resolved.   It was unknown if the reporter considered the pain in arm and swelling arm to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and had pain in arm and swelling arm. For tolerances of 2nd dose, refer case US2020003258, reported by same reporter and patient. This case linked US2020AMR003672 and US2020003251, reported by same reporter. The reporter did not give consent to follow up.
Received vaccine at about 0830 on 12/24/20, at about 0100 on 12/25/20 started feeling lethargic then developed nausea and vomiting, additionally had mild to moderate shaking chills and mild myalgias.  Went to sleep and resolved when woke up in AM.
Redness, swelling at site of injection, pain (swelling 3in wide x 7in long).
Breakout in Hives eyes swelling  out for two days taking benadryl hives and rash continued over couple of days
Sore area around injection site, irregular temperature, severe fatigue - fatigue lasted the equivalent of two days with the next full day after injection being the worst.  The day after the injection fatigue was debilitating requiring sleeping or resting for most of the day and night. Half way through the second day after the injection fatigue is still present though significantly improved. The Item 21 box for Doctor visit has been checked as I will meet with my primary care provider as soon as possible and have already discussed it with my employer's health department.
presented with cough;  + covid; CRP normal; D-dimer 3.0 trended down to 1.5; Ferritin 663 trended down to 577;  CXR clear; O2 between 2-4 LPM NC during stay; discharged at 2 LPM; Tx: Vit C, Decadron, Eliquis, Rocephin, Vit D3, Singulair, Zinc; No remdesivir due to AKI and no actemra or baricitanib due to normal CRP;
About 2 minutes after the injection, patient became unconscious.  His pulse was present but he was out for about 5-6 seconds.  When he   gained consciousness, he stood up and looked around frighteningly.  we called the paramedics who came and checked on him.  Patient was advised to go with them to the hospital despite the facts that his numbers was unimpressive.  However, patient did not take their advice.  He stated that he did skip breakfast that morning because he was in the rush.  Patient described his feeling after waking up from the black out as spinning for a few seconds.  We called and checked on him after he had gone home after 2 hours.  He stated that he felt much better .  Follow-up calls two days after the incident was unsuccessful.  His voice mail was full so we could not leave message.
Baby was given 2 shots at her 4 month checkup. She was given the DTaP (not sure which version above) and the PREVNAR. She literally slept for an entire weekend only staying up for 4 hours throughout the day in small one hour stretches. She was eating normally and sleeping through the night as well as her excessive napping. This continued for 3 full consecutive days after receiving the shot. She is still mushy on the Tuesday after getting the shots on Friday.
Patient received Pfizer COVID vaccine on 12/23/20. On 1/13/2021, patient was scheduled to receive 2nd dose of Pfizer vaccine, but received Moderna vaccine. location is a drive through vaccine clinic and was giving both vaccines on this date due to supply and logistics. On days when both vaccines are given, there are individuals assigned to each vaccine for check-in, vaccinator and scheduler. Color cards of green/red (Moderna) and orange/blue (Pfizer) along with face sheet are placed on the windshields to communicate which vaccine is to be administered. Unclear if incorrect color was assigned to vehicle or if vaccinator did not perform safety checks with color cards and face sheet.
Medication Administration Error. Patient received 0.25 mL of Moderna bivalent vaccine instead of 0.5 mL at office visit.  The patient was contacted when the error was discovered and will return to the clinic at a later date to receive an additional dose.
Rash spread to legs, vagina and around buttocks; Rash on injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash spread to legs, vagina and around buttocks) and VACCINATION SITE RASH (Rash on injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash spread to legs, vagina and around buttocks) and VACCINATION SITE RASH (Rash on injection site). The patient was treated with TERBINAFINE HYDROCHLORIDE (LAMISIL [TERBINAFINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency and KETOCONAZOLE for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (Rash spread to legs, vagina and around buttocks) outcome was unknown and VACCINATION SITE RASH (Rash on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported.
Bilateral itchy rash, mostly with small areas of erythema especially around arm pits, but also on abdomen, back, neck, arms, forearms, thighs, legs; Bilateral itchy rash, mostly with small areas of erythema especially around arm pits, but also on abdomen, back, neck, arms, forearms, thighs, legs; some less erythematous areas of swelling with well-marked borders at most 1cm in diameter; This is a spontaneous report from a contactable physician. A 28-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly, on 15Dec2020 at 02:45 (at the age of 28-years-old) at a single dose for COVID-19 immunization. Medical history included hypertension (HTN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications, taken within two weeks of vaccination, included lisinopril (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN), and vitamin D (MANUFACTURER UNKNOWN) taken for supplement. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced bilateral itchy rash, mostly with small areas of erythema especially around arm pits, but also on abdomen, back, neck, arms, forearms, thighs, legs and some less erythematous areas of swelling with well-marked borders at most 1cm in diameter on 16Dec2020 at 08:00. The events did not cause or prolong hospitalization. Therapeutic measures were taken as a result of the events, which included treatment with diphenhydramine hydrochloride (BENADRYL) and loratadine (CLARITIN). The events improved with loratadine but started to reoccur 18 hours after loratadine use. The clinical outcome of bilateral itchy rash, mostly with small areas of erythema especially around arm pits, but also on abdomen, back, neck, arms, forearms, thighs, legs and some less erythematous areas of swelling with well-marked borders at most 1cm in diameter was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.
Patient reported to outpatient clinic and stated he wanted to receive a Covid-19 vaccine. He was screened appropriately and patient declined ever receiving a first dose. The hospital is giving out gift cards for every dose received and the patient kept asking how to redeem his gift card. I checked "database and our electronic health record and no dose had been reported. I gave the dose and educated the patient on side effects. Approximately 30 minutes later, the patient's wife reported to the clinic and gave me her husbands vaccination card from a previous dose he had received. The patient had originally received a first dose of the Pfizer vaccine on 10/07/2021.  Patient and wife were both educated about the "error" and he was counselled on the appropriate action to take if he started to feel ill.
her face got swollen; lymph node right there it was extremely swollen and very tender and very painful; She had a lump at the site of the injection; chills; headache; flu like symptoms; This is a spontaneous report from a contactable consumer.  A 60-years-old female patient received the second dose of bnt162b2 (BNT162B2; Lot # EL8982) vaccine  , via an unspecified route of administration on  20Jan2021 at single dose  for covid-19 immunisation .  Medical history included hypertension.  Concomitant medication included telmisartan (MICARDIS). On 30Dec2021 the patient received the first dose of BNT162B2 vaccine. The patient experienced her face got swollen on an unspecified date with outcome of unknown , lymph node right there it was extremely swollen and very tender and very painful  on an unspecified date with outcome of unknown , she had a lump at the site of the injection  on an unspecified date with outcome of unknown , chills on an unspecified date with outcome of unknown , headache  on an unspecified date with outcome of unknown , flu like symptoms  on an unspecified date with outcome of unknown. The events swollen face and lymph adenopathy were considered important medical Events. The remaining events were considered non serious. The patient stated she got the second vaccine shot of Pfizer on Wednesday the 20Jan2021. She got like a weird side effect like under her armpit it got really swollen and painful, like the lymph node right there it was extremely swollen and very tender and very painful. It still is but not as much. The next day  the right side of her face was swollen   The patient received Tylenol as treatment for the events.  Follow up information has been requested.
4 days after vaccination the girl started with edema and pain in the right side of the face. Tx: antibiotics IV for 24 hours. (Note at bottom of form): The girl is fine.
Severe swelling, chills, sweating, nausea, weight loss. Severe pain. Pt reports out of body experience/delerium she thinks due to the pain for 48 hours. Pt has treated with ice, rest, and some exercises she was told to do by her provider. Pt states she has had similar reactions in the past to prednisone and dexamethasone injections.
Fuzzy head; fever; Myalgia; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Fuzzy head), PYREXIA (fever), MYALGIA (Myalgia ) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Fuzzy head), PYREXIA (fever), MYALGIA (Myalgia ) and HEADACHE (headache). At the time of the report, FEELING ABNORMAL (Fuzzy head), PYREXIA (fever), MYALGIA (Myalgia ) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.
I was notified on 2/22/21 that this patient passed away over the weekend. I do not know the details, nor can I confirm anything beyond what I was told. I believe the death occurred on 2/20/21 due to a massive stroke.
The pt experienced swelling of the face 1 day post vax. Returned to the clinic and was placed on Prednisone, but swelling increased. Presented to the ER 2 days post vax and treated with Benadryl.
Fever began around 9pm the same day as getting a Moderna booster. Was not able to sleep because of fever, extreme headache, and all over body soreness. The next day, my head was throbbing, fever was persistent, and had trouble eating. Would experience nausea with every bite. Symptoms continued through the morning of 11/20 (currently still having symptoms).
Patient had arm soreness, swelling, warmth, and pain at injection site.  Patient also said that her arm still feels really weak.